CAMBRIDGE, Mass., July 21, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conferencecall on Thursday, August 3, 2017, at 4:30 p.m. ET to review its second quarter 2017 financial results and provide an update on the company.
A live webcast of the conference call can
About Infinity Infinity is an innovative biopharmaceutical company dedicated to advancing novel medicines for people with cancer. Infinity is advancing IPI-549, an oral immuno-oncology development candidate that selectively inhibits PI3K-gamma. A Phase 1 study in patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.
Contact: Jaren Irene Madden, Senior Director, Investor Relations and Corporate Communications Jaren.Madden@infi.com
View original content:http://www.prnewswire.com/news-releases/infinity-announces-the-date-of-its-second-quarter-2017-financial-results-conference-call-and-webcast-300491966.html
SOURCE Infinity Pharmaceuticals, Inc.
Subscribe to our Free Newsletters!
A patient's struggle with Issacs' syndrome with no cure. Also known as neuromyotonia it is a rare ...
Inguinal hernia surgery is a procedure to repair a weak spot or defect in the lower wall of the ...
Hypopituitarism is a rare disorder resulting from decreased secretion of one or more of the ...View All